prov:value
| - For example, for treatment of a neurodegenerative disease, in particular Alzheimer's disease, an inhibitor of AGE-formation can be administered in conjunction with a therapy designed to inhibit production of ??AP, such as those described by Gandy et al., U.S. Pat. No. 5,242,932, issued Sep. 7, 1993; Wagner et al., International Patent Publication No. WO 93/09233, published May 13, 1993; and Buxbau
|